Since the molecular characteristics of CDX2-negative tumors are predominantly those with BRAF mutation, CIMP, and MSI and frequently found in female patients with right-sided tumors, we hypothesized that CDX2 loss could play a functional role in tumors derived from the serrated pathway, a route of CRC development originating from the serrated adenoma. This evidence concerns the gene CDX2 and colorectal carcinoma.